skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Liu, Enchi remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Salloway, Stephen ; Sperling, Reisa ; Fox, Nick C ; Blennow, Kaj ; Klunk, William ; Raskind, Murray ; Sabbagh, Marwan ; Honig, Lawrence S ; Porsteinsson, Anton P ; Ferris, Steven ; Reichert, Marcel ; Ketter, Nzeera ; Nejadnik, Bijan ; Guenzler, Volkmar ; Miloslavsky, Maja ; Wang, Daniel ; Lu, Yuan ; Lull, Julia ; Tudor, Iulia Cristina ; Liu, Enchi ; Grundman, Michael ; Yuen, Eric ; Black, Ronald ; Brashear, H. Robert

The New England journal of medicine, 2014-01, Vol.370 (4), p.322-333 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease
Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease

Novak, Gerald ; Fox, Nick ; Clegg, Shona ; Nielsen, Casper ; Einstein, Steven ; Lu, Yuan ; Tudor, Iulia Cristina ; Gregg, Keith ; Di, Jianing ; Collins, Peter ; Wyman, Bradley T ; Yuen, Eric ; Grundman, Michael ; Brashear, H Robert ; Liu, Enchi Scheltens, Philip

Journal of Alzheimer's disease, 2016-01, Vol.49 (4), p.1123-1134 [Periódico revisado por pares]

Netherlands

Texto completo disponível

Citações Citado por
3
P1–356: Correlation of brain atrophy with clinical progression in mild‐to‐moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
P1–356: Correlation of brain atrophy with clinical progression in mild‐to‐moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

P1–356: Correlation of brain atrophy with clinical progression in mild‐to‐moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

Novak, Gerald ; Einstein, Steven ; Lu, Yuan ; Tudor, Iulia Cristina ; Gregg, Keith ; Collins, Peter ; Wyman, Bradley ; Yuen, Eric ; Nielsen, Casper ; Grundman, Michael ; Brashear, Robert H. ; Fox, Nick ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_7), p.P289-P289 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
P1–352: The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
P1–352: The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

P1–352: The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

Novak, Gerald ; Einstein, Steven ; Tudor, Iulia Cristina ; Gregg, Keith ; Collins, Peter ; Wyman, Bradley ; Yuen, Eric ; Nielsen, Casper ; Grundman, Michael ; Brashear, Robert H. ; Fox, Nick ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_7), p.P287-P287 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials
IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

IC‐P‐015: Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials

Margolin, Richard ; Schmidt, Mark ; Gregg, Keith ; Les, Andrea ; Hill, Derek ; Koeppe, Robert ; Wyman, Bradley ; Styren, Scot ; Grundman, Michael ; Yuen, Eric ; Brashear, Robert H. ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_1), p.P18-P18 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials
Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of the pons as a reference region for amyloid PET in Alzheimer's disease clinical trials

Margolin, Richard ; Schmidt, Mark ; Gregg, Keith ; Les, Andrea ; Hill, Derek ; Koeppe, Robert ; Wyman, Bradley ; Styren, Scot ; Grundman, Michael ; Yuen, Eric ; Brashear, Robert H ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P18-P18 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
7
The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

Novak, Gerald ; Einstein, Steven ; Tudor, Iulia Cristina ; Gregg, Keith ; Collins, Peter ; Wyman, Bradley ; Yuen, Eric ; Nielsen, Casper ; Grundman, Michael ; Brashear, Robert H ; Fox, Nick ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P287-P287 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
8
Effect of bapineuzumab on CSF p-tau and t-tau in mild-to-moderate Alzheimer's disease: Results from two phase III trials in APOE-ε4 carriers and noncarriers
Effect of bapineuzumab on CSF p-tau and t-tau in mild-to-moderate Alzheimer's disease: Results from two phase III trials in APOE-ε4 carriers and noncarriers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of bapineuzumab on CSF p-tau and t-tau in mild-to-moderate Alzheimer's disease: Results from two phase III trials in APOE-ε4 carriers and noncarriers

Streffer, Johannes ; Blennow, Kaj ; Salloway, Stephen ; Zetterberg, Henrik ; Xu, Yi-Zheng ; Lu, Yuan ; Lull, Julia ; Collins, Peter ; Tudor, Iulia Cristina ; Gregg, Keith ; Styren, Scot ; Yuen, Eric ; Grundman, Michael ; Brashear, Robert H ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P138-P138 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC-001 (vanutide cridificar) for Alzheimer's disease
Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC-001 (vanutide cridificar) for Alzheimer's disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC-001 (vanutide cridificar) for Alzheimer's disease

Margolin, Richard ; Ketter, Nzeera ; Guthrie, Spencer ; Deegan, Denise ; Baher, Linda ; Tschopp, Renee ; Marek, Kenneth ; Seibyl, John ; Novak, Gerald ; Streffer, Johannes ; Pachai, Chahin ; Wyman, Bradley ; Booth, Kevin ; Yuen, Eric ; Gennevois, Daniel ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P289-P290 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

Novak, Gerald ; Einstein, Steven ; Lu, Yuan ; Tudor, Iulia Cristina ; Gregg, Keith ; Collins, Peter ; Wyman, Bradley ; Yuen, Eric ; Nielsen, Casper ; Grundman, Michael ; Brashear, Robert H ; Fox, Nick ; Liu, Enchi

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P289-P289 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (14)
  2. Revistas revisadas por pares (14)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.